| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Oct 7, 2020A World's First That Combines Innovative Technologies: Titan nanoLOCK™ Surface Technology and NavigationMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. launch of Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™...
-
Oct 6, 2020
Medtronic plc (NYSE:MDT) today announced that Omar Ishrak has decided not to stand for re-election at the Annual General Meeting in December and will retire as Executive Chairman and Chairman of...
-
Oct 6, 2020ELITE is the Only Study of a Rechargeable Sacral Neurostimulation System to Include All Four Indications, Including Fecal Incontinence, Which Affects Millions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient was implanted in its ELITE study of the InterStim™ Micro system — the only study of a...
-
Oct 5, 2020
Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Event on Wednesday, October 14, 2020, from 8:00 a.m. to approximately 2:00 p.m....
-
Oct 1, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy...
-
Sep 30, 2020
Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with...
-
Sep 29, 2020
Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ("Medtronic Luxco") has closed a registered public offering (the...
-
Sep 25, 2020U.S. Patent and Trademark Office Rejects IPR Challenge to Medtronic Patent
Medtronic (NYSE:MDT) has won an important victory in a patent dispute over intellectual property for its sacral neuromodulation device family, the InterStim™ systems. The Patent Trial and Appeal...
-
Sep 24, 2020
Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering (the "Offering") of...
-
Sep 23, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™...
-
Sep 22, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the TYRX™ Absorbable...
-
Sep 16, 2020Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope)...
-
Sep 11, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September...
-
Sep 10, 2020PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD)
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of primary data from PRODIGY (PRediction of Opioid-induced respiratory Depression In patients...
-
Sep 9, 2020
Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid™...
-
Sep 4, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020.
-
Sep 1, 2020New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2
DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
-
Aug 29, 2020ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores
DUBLIN, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results demonstrating superiority of the Arctic Front™...
-
Aug 25, 2020Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic
DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020. The company reported...
-
Aug 24, 2020
DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September...
-
Aug 24, 2020
DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) on Friday, August 21, 2020, approved the fiscal year 2021 second quarter cash dividend of $0.58 per...
-
Aug 21, 2020Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR)
DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised...
-
Aug 20, 2020ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary Retention
DUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global,...
-
Aug 19, 2020Results Showed IN. PACT™ AV DCB Is Safe, Reduces Reinterventions, and Helps Maintain Dialysis Access for Those Living with End-Stage Renal Disease
DUBLIN, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Medtronic announced today the publication of the primary endpoint results from the IN.PACT AV Access trial in The New England Journal of Medicine.1 The...
-
Aug 11, 2020
DUBLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, August 25, 2020. A...